Latest news
Loading news…
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Emalex Biosciences was acquired by Teva Pharmaceutical Industries Ltd. in 2026.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
15
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Chicago, Illinois, United States
Acquisitions by Emalex Biosciences
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Emalex Biosciences
Chief Medical Officer
15
professional contacts at Emalex Biosciences
Contact execs at Emalex Biosciences →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Emalex Biosciences
Loading news…
FAQs about Emalex Biosciences
People who checked this page also checked these
Sectors Emalex Biosciences invests & acquires in
Browse the full Acquirezy directory.